Voltage-dependent Ca
Keywords: calcium channel blockers; drug binding domains
Jörg Striessnig, University of Innsbruck, Innsbruck, Austria
Hartmut Glossmann, University of Innsbruck, Innsbruck, Austria
Published online: September 2005
DOI: 10.1038/npg.els.0004060
Voltage-dependent Ca
Keywords: calcium channel blockers; drug binding domains
| References | |
| Catterall WA and Striessnig J (1992) Receptor sites for calcium antagonists. Trends in Pharmacological Sciences 13: 256262. | |
| Glossmann H, Ferry DR, Goll A, Striessnig J and Zernig G (1985) Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittelforschung/Drug Research 35: 19171935. | |
| Hockerman GH, Peterson BZ, Johnson BD and Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annual Review of Pharmacology and Toxicology 37: 361396. | |
|
Huber I,
Wappl E,
Herzog A et al.
(2000)
Conserved Ca | |
|
Koschak A,
Reimer D,
Huber I et al.
(2001)
1D (Cav1.3) subunits can form L-type Ca | |
|
Jiang Y,
Ruta V,
Chen J,
Lee A and
MacKinnon R
(2003)
The principle of gating charge movement in a voltage-dependent K | |
| Kraus RL, Sinnegger MJ, Glossmann H, Hering S and Striessnig J (1998) Familial hemiplegic migraine mutations change alpha1A calcium channel kinetics. Journal of Biological Chemistry 273: 55865590. | |
| Lew MJ, Flinn JP, Pallaghy PK et al. (1997) Structurefunction relationships of omega-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. Journal of Biological Chemistry 272: 1201412023. | |
| Miljanich GP and Ramachandran J (1995) Antagonists of neuronal calcium channels: structure, function and therapeutic implications. Annual Review of Pharmacology and Toxicology 35: 707734. | |
| Pietrobon D and Striessnig J (2003) Neurobiology of migraine. Nature Reviews Neuroscience 4: 386398. | |
|
Platzer J,
Engel J,
Schrott-Fischer A et al.
(2000)
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca | |
| Striessnig J, Grabner M, Mitterdorfer J et al. (1998) Structural basis of drug binding to L calcium channels. Trends in Pharmacological Sciences 19: 108115. | |
|
Zhorov BS,
Folkman EV and
Ananthanarayanan VS
(2001)
Homology model of dihydropyridine receptor: implications for L-type Ca | |
| Further Reading | |
| Deisseroth K, Mermelstein PG, Xia H and Tsien RW (2003) Signaling from synapse to nucleus: the logic behind the mechanisms. Current Opinion in Neurobiology 13: 354365. | |
| book Fleckenstein A (1983) Calcium Antagonism in Heart and Smooth Muscle. New York: Wiley. | |
| Glossmann H and Striessnig J (1990) Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology 114: 1105. | |
|
Hofmann F,
Biel M and
Flockerzi V
(1994)
Molecular basis for Ca | |
| Lewis RJ and Garcia ML (2003) Therapeutic potential of venom peptides. Nature Reviews Drug Discovery 2: 790802. | |
| Olivera BM, Rivier J, Clark C et al. (1990) Diversity of Conus neuropeptides. Science 249: 257263. | |
| Perez-Reyes E (2003) Molecular physiology of low-voltage-activated t-type calcium channels. Physiological Reviews 83: 117161. | |
| Triggle DJ and Janis RA (1987) Calcium channel ligands. Annual Review of Pharmacology and Toxicology 27: 347369. | |